Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian stock markets open flat
Wed, 11 May 09:30 am

All Asian stock markets have opened the day on a firm note. Stock markets in Singapore (up 0.5%), Japan (up 0.5%), South Korea (up 0.8%) and Malaysia (up 0.9%) are leading the gains. Indian stock markets have opened the day on a flat note. Stocks from the technology and realty space are trading firm. However, FMCG and healthcare stocks are trading in the red.

The BSE-Sensex is trading marginally higher by around 5 points (0.03%), while the NSE-Nifty is up by around 5 points (0.1%). However, mid and small cap stocks are trading firm with both the BSE Midcap index and BSE Small cap index up by 0.1% and 0.2% respectively. The rupee is trading at 44.67 to the US dollar.

Pharma stocks have opened the day on a weak note with Sun Pharma, Divi's Lab and Lupin trading in the red. However, Ranbaxy Labs is trading firm. Indian pharma major Ranbaxy Labs has declared its results for the first quarter ended March 2011 (the company has a December year ending). Consolidated sales registered a decline of 14% YoY from Rs 24.8 bn in 1QCY10 to Rs 21.5 bn in 1QCY11. While sales in emerging markets grew by 12% YoY (Rs 10.6 bn), the developed markets posted a decline of 30% YoY (Rs 9.5 bn). The bottomline dropped by 68% YoY from about Rs 9.6 bn in 1QCY10 to approximately Rs 3 bn in 1QCY11. However, the company has stated that the revenue and profit numbers are not strictly comparable to the previous period as the numbers in the previous quarter included one-time upside of the exclusive marketing opportunities in the US market.

Banking stocks have also opened the day on a weak note with United Bank, Oriental Bank and State Bank of India (SBI) trading in the red. The country's largest bank, SBI has raised its lending rates by 0.75%. The minimum lending rate for SBI now stands at 9.25%. The benchmark prime lending rate now stands at 14%. SBI has also increased the interest rates on its deposits. It has increased the rates by 2.25% for four of its deposit products. The increase in interest rates follows the announcement made by the Reserve Bank of India wherein it had hiked its lending and borrowing rates by 0.5%. The increase in interest rates by SBI would make its housing as well as other loans more expensive for the borrowers. Several other banks including Punjab National Bank and ICICI Bank have increased their interest rates over the past few days.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian stock markets open flat". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.